Picture of Pacific Biosciences of California logo

PACB — Pacific Biosciences of California News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Pacific Biosciences of California Inc reports results for the quarter ended in December - Earnings Summary

* Pacific Biosciences of California Inc  PACB.OQ  reported a
quarterly adjusted loss of 31 cents​​ per share for the quarter
ended in December, higher than the same quarter last year, when
the company reported EPS of -37 cents.  The mean expectation of
fifteen analysts for the quarter was for a loss of 29 cents per
share. Wall Street expected results to range from -35 cents
to -24 cents per share.
    * Revenue rose 113.3% to $58.36 million from a year ago;
analysts
expected $57.49 million. 
    * Pacific Biosciences of California Inc's reported EPS for
the
quarter was a loss of 31 cents​.
    * The company reported a quarterly loss of $82.02 million.
    * Pacific Biosciences of California Inc shares had fallen
by 33.7%
this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.1%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Pacific
Biosciences of California Inc is $12.00 
This summary was machine generated from LSEG data February 15 at
11:29 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.29          -0.31          Missed
 Sep. 30 2023      -0.33          -0.26          Beat
 Jun. 30 2023      -0.32          -0.28          Beat
 Mar. 31 2023      -0.33          -0.36          Missed

Recent news on Pacific Biosciences of California

See all news